Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 670809, 7 pages
http://dx.doi.org/10.1155/2015/670809
Case Report

Characteristics and Treatment Results of 5 Patients with Fibrous Dysplasia and Review of the Literature

1Endocrinology Department, Ege University Faculty of Medicine, Izmir, Turkey
2Endocrinology Department, Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey

Received 10 January 2015; Accepted 1 June 2015

Academic Editor: Suat Simsek

Copyright © 2015 Nilufer Ozdemir Kutbay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Shenker, L. S. Weinstein, D. E. Sweet, and A. M. Spiegel, “An activating Gsα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 3, pp. 750–755, 1994. View at Google Scholar · View at Scopus
  2. R. D. Chapurlat and P. Orcel, “Fibrous dysplasia of bone and McCune-Albright syndrome,” Best Practice & Research: Clinical Rheumatology, vol. 22, no. 1, pp. 55–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lichtenstein, “Polyostotic fibrous dysplasia,” Archives of Surgery, vol. 36, no. 5, pp. 874–898, 1938. View at Publisher · View at Google Scholar
  4. M. J. Kransdorf, R. P. Moser, and F. W. Gilkey, “Fibrous dysplasia,” Radiographics, vol. 10, pp. 519–537, 1990. View at Google Scholar
  5. L. Feller, N. H. Wood, R. A. Khammissa, J. Lemmer, and E. J. Raubenheimer, “The nature of fibrous dysplasia,” Head and Face Medicine, vol. 5, article 22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Thomsen and L. Rejnmark, “Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia,” Calcified Tissue International, vol. 94, no. 4, pp. 384–395, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Xu, X. Li, C. S. Lv et al., “Treatment protocols for growth hormonesecreting pituitary adenomas combined with craniofacial fibrous dysplasia: a case report of atypical McCune-Albright syndrome,” Experimental and Therapeutic Medicine, vol. 8, pp. 877–880, 2014. View at Google Scholar
  8. R. D. Chapurlat, “Medical therapy in adults with fibrous dysplasia of bone,” Journal of Bone and Mineral Research, vol. 21, no. 2, pp. 114–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Liens, P. D. Delmas, and P. J. Meunier, “Long-term effects of intravenous pamidronate in fibrous dysplasia of bone,” The Lancet, vol. 343, no. 8903, pp. 953–954, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Parisi and B. Oliveri, “Long-term pamidronate treatment of polyostotic fibrous dysplasia of bone: a case series in young adults,” Current Therapeutic Research—Clinical and Experimental, vol. 70, no. 2, pp. 161–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Boyce, M. H. Kelly, B. A. Brillante et al., “A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. 4133–4140, 2014. View at Publisher · View at Google Scholar
  12. B. Hanifi, K. S. Samil, C. Yasar, C. Cengiz, A. Ercan, and D. Ramazan, “Craniofacial fibrous dysplasia,” Clinical Imaging, vol. 37, no. 6, pp. 1109–1115, 2013. View at Publisher · View at Google Scholar · View at Scopus